ArticleCancers2025

Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation.

Arnau Torrent-Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.